Center for Molecular Diversity in Drug Design, Discovery and Delivery (CMD5)

The University of South Florida (USF) has established the Center for Molecular Diversity in Drug Design, Discovery and Development (CMD5) that takes advantage of existing strengths and cross disciplinary resources in the College of Arts and Sciences, the College of Medicine, the College of Pharmacy, the H. Lee Moffitt Cancer Center and Research Institute, and the Byrd Alzheimer's Institute. CMD5 fosters active collaboration among scientists from these institutions in several disciplines which rely upon advances in molecular science to understand the causes of human disease, develop novel methods for its prevention, and devise novel therapies and treatments.

Thus Mission of CMD5 is "The discovery, design, synthesis and development of new drug lead compounds and drug delivery modes for the prevention and cure of human diseases".

CMD5 Areas of Investigation:

  • Drug synthesis and delivery
  • Alzheimers/Parkinsons drugs
  • Synthetic methodologies
  • Bioanalytical methods
  • Nanoparticle antibiotics
  • Protein synthesis
  • Bioassay development
  • Antibiotics and anticancer agents
  • Natural products
  • Nutraceutical R&D
  • Biopolymer design and synthesis
  • Computer-aided drug design
  • Bio-NMR and mass spectrometry
  • High-throughput biotesting

Copies of the CMD5 brochure and Flyer are available for download below.